Addressing the Challenges of Serogroup B Meningococcal Disease Outbreaks on Campuses Monday, November 17, [removed]:00 PM ET

First Page		Document Content
Biology Meningococcal disease Pfizer Sanofi Pasteur Vaccination NmVac4-A/C/Y/W-135 Meningococcal vaccine Vaccines Prevention Medicine		Addressing the Challenges of Serogroup B Meningococcal Disease Outbreaks on Campuses Monday, November 17, [removed]:00 PM ET Add to Reading List Source URL: www.nfid.org Download Document from Source Website File Size: 1,57 MB Share Document on Facebook

	Vassar College Meningococcal Meningitis Facts Please keep for your records New York State Department of Health — Bureau of Communicable Disease Control / Meningococcal Disease DocID: 1vdbA - View Document
	Vassar College Meningococcal Meningitis Facts Please keep for your records New York State Department of Health — Bureau of Communicable Disease Control / Meningococcal Disease DocID: 1tI29 - View Document
	April 17, 2015 Memo of Support A.791/S.4324 An act to amend public health law in relation to requiring vaccination against meningococcal disease The NYS AAP, representing more than 4,100 pediatricians across New York Sta DocID: 1sqGa - View Document
	Meningitis Statement Georgia state law requires all students residing in University housing to receive information about meningococcal disease. Evidence suggests that college students are at an increased risk of contract DocID: 1rsYu - View Document
	New York State Department of Health DocID: 1rfHH - View Document